top of page
it's where dermatology lives
John Evans
Dec 2, 20222 min read
Abnormal expression of Lepr leptin receptor may drive SSC malignancy
In a study of RAS gene mutations in squamous cell carcinoma, researchers have found that a single mutated gene in an otherwise healthy...
John Evans
Nov 25, 20222 min read
Highest risk of multiple primary melanomas from indoor tanning
Findings from a case-control study show that a history of indoor tanning is the strongest risk factor for the development of multiple...
John Evans
Nov 18, 20221 min read
Nivolumab shows promise in advanced cutaneous squamous cell carcinoma
Findings from a recent phase II clinical trial show promising results for the immune checkpoint inhibitor nivolumab in the treatment of...
Allan Ryan
Nov 7, 20221 min read
Models predict low mortality in certain patients with stage 1 melanoma
According to a new study, models based on cancer registry data can help identify subsets of stage 1 melanoma patients with very low...
John Evans
Oct 28, 20222 min read
Relatlimab/nivolumab combo improves melanoma outcomes, may avoid surgery
Findings from a study of patients with stage III melanoma treated with a combination of the immune checkpoint inhibitors relatlimab and...
Allan Ryan
Oct 24, 20221 min read
New molecule may block melanoma growth
Researchers at Emory University in Atlanta have synthesized a novel molecule called indolium 1 that blocks the growth of melanoma cells,...
John Evans
Sep 30, 20222 min read
New technology for rapid bedside skin cancer biopsy diagnosis
A pilot study of a new biopsy imaging system has shown high accuracy in diagnosing non-melanoma skin cancer in two minutes—substantially...
Jeremy Visser
Sep 28, 20221 min read
VIDEO: Suppressing key metabolic enzyme may stop melanoma growth, new study shows
A new study has discovered that by inhibiting the key metabolic enzyme GCDH, melanoma cells can be selectively killed to halt tumour growth.
Featured Posts
bottom of page